Plain-English translation of NCT06890767 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a wearable device that tracks several health measurements—like your heart rate, oxygen levels, breathing rate, activity, sleep, and body temperature—to help catch flare-ups of chronic lung disease (COPD) early. The device sends this information so doctors can spot warning signs before symptoms get worse and you need to go to the hospital. The goal is to see whether this kind of home monitoring can help prevent serious flare-ups and keep you healthier.
Right now, doctors don't have a good way to monitor lung disease patients when they're at home, which means warning signs of a dangerous flare-up can be missed. This trial exists to see whether wearable technology can catch these warning signs early enough for doctors to step in and prevent a hospital visit.
You likely qualify if…
You likely don't qualify if…
When you arrive at the hospital with a lung disease flare-up, you will be given a wearable device to wear. This device will continuously track your heart rate, oxygen levels, breathing, activity, sleep patterns, and body temperature. You'll wear it during your hospital stay and possibly after, and the device will send your health information to your doctor so they can monitor how you're doing. The study involves 50 patients total and is designed to help doctors better understand how to spot and treat flare-ups early.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
Belgium